大剂量碘对比剂外渗:单中心67,000余例队列中低频次且保守处理后转归良好
该回顾性单中心队列纳入2008年1月至2016年9月接受静脉非离子型碘对比剂检查的67,129例患者,大剂量对比剂外渗(≥20 ml)总体发生率为0.04%(27/67,129),无患者出现严重体征或需外科干预,多数在7天内恢复;因缺乏对照组且为回顾性研究,管理方案与外渗后良好转归之间的因果关系无法被彻底审查。
要点
- 大剂量对比剂外渗(≥20 ml)总体发生率为0.04%(27/67,129)。
- 无患者出现严重体征或需外科干预,多数在7天内恢复。
- 肿胀和疼痛是最常见症状。
核心结论
- 大剂量碘对比剂外渗发生率很低,无严重并发症或后遗症;因研究缺乏对照组且为回顾性,管理方案与良好转归之间的因果关系无法被彻底审查。
研究设计与样本
- 回顾性单中心队列研究,纳入2008年1月至2016年9月接受静脉非离子型碘对比剂给药的67,129例患者,仅纳入CT和静脉尿路造影中的对比剂外渗事件(不含血管造影),所有数据前瞻性收集,按年龄、注射方式(手动 vs 自动注射)、多种预防外渗手段(包括对讲机报警)及外渗处理(常规涂抹磺胺嘧啶银软膏、丙酸氯倍他索乳膏及室温湿纱布)等进行分层。
诊断标准与关键数值
- 大剂量对比剂外渗总体发生率为0.04%(27/67,129)。
- 手动注射相关外渗发生率为0.03%,年龄范围59-92岁,平均75.4岁。
- 自动注射相关外渗发生率为0.045%,年龄范围36-86岁,平均65.8岁。
- 手动注射组中外渗对比剂体积为20-40 ml者占5/9(55.6%),自动注射组占14/18(77.8%)。
临床应用与阅片要点
- 肿胀和疼痛是最常见症状。
- 无患者出现严重体征或需外科干预,多数在7天内恢复。
- 作者认为其管理方案的每个要素均对良好转归有贡献。
局限性
- 该研究为回顾性研究。
- 研究缺乏对照组,因此无法彻底审查其管理方案与良好转归之间的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Our aim was to retrospectively investigate the frequency and outcome of large-volume iodinated contrast medium (CM) extravasation in our institution and to compare our management protocol to current practice.
METHODS: Institutional review board approval was obtained, and informed consent was waived because the study was retrospective. From January 2008 to September 2016, radiological examinations with intravenous non-ionic iodinated CM administration were performed in 67,129 patients. Contrast medium extravasation events on CT scans and intravenous pyelograms but not on angiograms were included. All data were collected prospectively and stratified according to age, injection method (manual vs auto-injection), prevention of extravasation by various means (including intercom alarm), management of extravasation (routine application of silver sulfadiazine ointment, clobetasol propionate cream, and damp gauze at room temperature), etc. RESULTS: The incidence of large-volume CM extravasation was very low (0.04% [27/67,129] overall; 0.03% related to manual injection [age range, 59-92 years; mean, 75.4 years], and 0.045% related to auto-injection [age range, 36-86 years; mean, 65.8 years]). The CM extravasation volume in majority of patients was 20-40 ml in 5 of 9 patients (55.6%) in the manual injection group and 14 of 18 (77.8%) in the auto-injection group. Swelling and pain were the most common symptoms. No patient developed severe signs or needed surgical intervention.
CONCLUSIONS: Results show a very low incidence of large-volume CM extravasation without severe complications or sequelae. The casual effect between our protocols and good outcome cannot be scrutinised thoroughly because the study lacks a control group and is retrospective.
KEY POINTS: • The incidence of large-volume contrast medium extravasation (≥20 ml) was 0.04%. • No patient needed surgical intervention, and most recovered within 7 days. • Each element of our management protocol contributed to good outcome.
引用
- Ko CH, Tay SY, Chang HC, et al. Large-volume iodinated contrast medium extravasation: low frequency and good outcome after conservative management in a single-centre cohort of more than 67,000 patients. Eur Radiol. 2018. PMID: 29948071. doi:10.1007/s00330-018-5514-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。